11/19/2025
✨ Recent studies suggest that GLP1 receptor agonists may be linked to improved survival rates in people with colon cancer. Researchers propose that these medications may influence inflammation and long-term outcomes in ways we are only beginning to understand.
🧬 Inflammation plays a key role in the development and progression of colon cancer, and exploring how GLP1 agonists interact with these pathways opens the door to new therapeutic perspectives. More research is needed, but the findings are promising.
-1 **alcancer